6 insiders reported 7 Form 4 transactions for Elicio Therapeutics, Inc. (ELTX) over the past 18 months (most recent 2026-02-03). Recent activity: Haqq Christopher (See Remarks) Buy 25,400 shares, DeMuth Peter (Chief Scientific Officer) Buy 20,800 shares, Shah Preetam (See Remarks) Buy 24,000 shares, Connelly Robert (CEO, President and Director) Buy 73,600 shares, DeMuth Peter (Chief Scientific Officer) Buy 362 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | Haqq Christopher | See Remarks | Buy | 25,400 | $0 |
| 2026-02-03 | DeMuth Peter | Chief Scientific Officer | Buy | 20,800 | $0 |
| 2026-02-03 | Shah Preetam | See Remarks | Buy | 24,000 | $0 |
| 2026-02-03 | Connelly Robert | CEO, President and Director | Buy | 73,600 | $0 |
| 2025-12-10 | DeMuth Peter | Chief Scientific Officer | Buy | 362 | $1,596 |
| 2025-03-07 | GKCC, LLC | Insider | Buy | 3.5M | $20.3M |
| 2025-03-07 | Chudnovsky Yekaterina | Director | Buy | 3.5M | $20.3M |
Source: SEC Form 4 filings · as of 2026-02-03